Milton Essex Spolka Akcyjna Logo

Milton Essex Spolka Akcyjna

Develops AI-powered, non-invasive systems for allergy diagnostics & personalized medicine.

MTN | WAR

Overview

Corporate Details

ISIN(s):
PLMLTNE00013
LEI:
259400QAFDSRLAIDCH26
Country:
Poland
Address:
WARSZAWA ŻOŁNY 42A, 02-815 WARSZAWA
Sector:
Professional, scientific and technical activities
Industry:
Research and experimental development on natural sciences and engineering

Description

Milton Essex S.A. is a medical technology company specializing in the development of innovative diagnostic systems that integrate artificial intelligence (AI), optoelectronics, and thermodynamics. The company's core focus is on revolutionizing allergy diagnostics and personalized medicine. Its flagship product, SkinSENS™, offers an automated, non-invasive method for diagnosing skin allergic reactions using hyperspectral imaging. Milton Essex is also expanding into biotechnology and develops other solutions, including the ActiveSCAN™ biometric system and multispectral skin imaging technologies. The company actively engages in research and development, leveraging technology transfer from partnerships, including the military sector, to advance its medical applications and improve patient outcomes.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2024-05-01 22:34
Declaration of Voting Results & Voting Rights Announcements
: Wykaz akcjonariuszy posiadających co najmniej 5% liczby głosów na Nadzwyczajn…
Polish 1.4 KB
2024-03-28 12:44
Post-Annual General Meeting Information
projekty uchwał na NWZA Spółki w dniu 23 kwietnia 2024
Polish 144.8 KB
2024-03-28 12:44
Pre-Annual General Meeting Information
Ogłoszenie o zwołaniu Nadzwyczajnego Walnego Zgromadzenia Milton Essex S.A. na …
Polish 653 bytes
2023-09-11 12:50
Investor Presentation
Strategia komercjalizacji Palety Produktowej Med-Tech System SkinSENS(tm) na la…
Polish 574.5 KB
2023-09-11 12:50
Report Publication Announcement
: Przyjęcie strategii komercjalizacji Systemu SkinSENS - Content (PL)
Polish 1.7 KB
2023-08-30 11:04
Registration Form
Decyzja Europejskiego Urzędu Patentowego o udzieleniu patentu Spółce - Content …
Polish 2.6 KB
2023-06-28 12:05
Major Shareholding Notification
Wykaz akcjonariuszy posiadających co najmniej 5% liczby głosów na Zwyczajnym Wa…
Polish 1.5 KB
2023-05-31 17:25
Pre-Annual General Meeting Information
Ogłoszenie o zwołaniu ZWZA MIlton Essex SA wraz z projektami uchwał
Polish 511.0 KB
2023-05-31 17:25
Pre-Annual General Meeting Information
Ogłoszenie o zwołaniu Zwyczajnego Walnego Zgromadzenia Milton Essex S.A. na dzi…
Polish 719 bytes
2023-05-25 12:58
Regulatory News Service
Kolejny etap procesu certyfikacji produktu SkinSens- Imaging System for in vivo…
Polish 2.2 KB
2023-05-15 18:04
Regulatory News Service
uzyskanie patentu przez Spółkę w Europejskim Urzędzie Patentowym - Content (PL)
Polish 2.6 KB
2023-05-11 16:05
Regulatory News Service
podpisanie umowy licencyjnej z ZURAD SP. z o.o. - Content (PL)
Polish 1.6 KB
2023-02-07 19:15
Regulatory News Service
uzyskanie patentu przez Spółkę w Japonii - Content (PL)
Polish 1.6 KB
2022-12-13 23:56
Regulatory News Service
: uzyskanie możliwości rozpoczęcia badań klinicznych SkinSense - Content (PL)
Polish 1.9 KB
2022-11-10 12:23
Declaration of Voting Results & Voting Rights Announcements
wykaz akcjonariuszy posiadających co najmniej 5% liczby głosów na Nadzwyczajny…
Polish 1.4 KB

Automate Your Workflow. Get a real-time feed of all Milton Essex Spolka Akcyjna filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

No Financial Data Available

Standardized financial statements for the selected period are not yet available.

Need More History? Access decades of standardized financials for Milton Essex Spolka Akcyjna via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Company Country Ticker View
OPTIBIOTIX HEALTH PLC Logo
Develops microbiome-modulating ingredients and supplements to manage chronic lifestyle diseases.
United Kingdom OPTI
OXFORD BIODYNAMICS PLC Logo
Develops precision blood tests using 3D genomics for cancer diagnosis and therapy guidance.
United Kingdom OBD
Pharnext Logo France ALPHA
PHYSIOMICS PLC Logo
De-risks oncology drug development for pharma/biotech using modeling and simulation.
United Kingdom PYC
PILA PHARMA AB Logo
Clinical-stage biopharma developing a first-in-class oral drug for diabetes and obesity.
Sweden PILA
POOLBEG PHARMA PLC Logo
AI-led biopharma developing drugs for high-need diseases like CRS and metabolic disorders.
United Kingdom POLB
PROTEOME SCIENCES PLC Logo
CRO providing proteomics services & TMT® tags to biopharma for drug discovery & biomarkers.
United Kingdom PRM
PROVEXIS PLC Logo
Develops & licenses Fruitflow®, a patented ingredient for heart health in food & supplements.
United Kingdom PXS
Develops uncopiable atomic fingerprints for anti-counterfeiting, verifiable by smartphone.
United Kingdom N/A
QUANTUM BLOCKCHAIN TECHNOLOGIES PLC Logo
R&D firm using AI and quantum computing to create efficient technologies for Bitcoin mining.
United Kingdom QBT

Talk to a Data Expert

Have a question? We'll get back to you promptly.